{{Rsnum
|rsid=2086824
|Gene=ANKRD11
|Chromosome=16
|position=89404838
|Orientation=plus
|GMAF=0.2498
|Gene_s=ANKRD11
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 21.2 | 55.8 | 23.0
| HCB | 93.4 | 6.6 | 0.0
| JPT | 81.4 | 17.7 | 0.9
| YRI | 97.3 | 2.7 | 0.0
| ASW | 73.7 | 24.6 | 1.8
| CHB | 93.4 | 6.6 | 0.0
| CHD | 91.7 | 7.3 | 0.9
| GIH | 60.4 | 37.6 | 2.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 50.0 | 44.8 | 5.2
| MKK | 71.8 | 26.3 | 1.9
| TSI | 20.6 | 52.9 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (IgH translocation)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=A
  |Pval=2E-6
  |OR=1.58
  |ORtxt=[1.31-1.91]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}